Juno Pharmaceuticals Canada sources, develops, and delivers life saving specialized pharmaceutical products for Canadian patients. 

Our colleagues work with trusted partners to co-develop novel drug delivery mechanisms that satisfy untapped market demand, first to market generic products, biosimilar offerings, and patent challenge strategies. 

Juno’s portfolio consists of both branded and generic drug assets in multiple presentation forms including injectable drugs (vials, amps, & pre filled syringes), complex biosimilars, ophthalmic products, oral does tablets and capsules, prescription dermatology topicals, and other unique dosage systems.

Our team have deep roots into the Canadian hospital space, retail pharmacy market, specialty channels, and a robust B2B platform. In addition, Juno Canada has recently embarked with product sourcing in the animal health space and remain focused on opening new delivery channels and customer groups to facilitate supply for Canadian patients.

Juno is proud to supply 5 molecules deemed medically necessary by the World Health Organization on their critically essential medications list, and we are actively pursuing export opportunities to countries in need of our critical medications.    

To learn more about Juno Pharmaceuticals Canada please contact us at communications@junopharm.com

For sales enquiries contact us at sales@junopharm.com

Health Care

Life Sciences

Pharmaceutical

Veterinary & Pet

Juno Pharmaceuticals Canada

Jean-Guy Goulet

Paul Varady

Greg Lamorre

Eric Guilbault

Michael Tersigni

Lynn McAllister

Juno Pharmaceuticals Canada

Org chart

Teams

Offices

Similar companies